Sunday
SESSION XLII: NEW DEVELOPMENTS IN CAS (4-MINUTE FAST PACED TALKS)
Moderators:Caron B. Rockman, MD / Giorgio M. Biasi, MD
SESSION XLII SCHEDULE
11:03 AM - 11:07 AM What The Trial And Registry Results To Date Tell Us About The Present Status Of CAS: What Are The Prospects For A Change In This Status In The Future?
  Presenters(s):Jörn O. Balzer, MD, PhD  
11:08 AM - 11:12 AM How To Lower Risk Of CAS In Octogenerians And Other High Risk Patients
  Presenters(s):Gary M. Ansel, MD  
11:13 AM - 11:17 AM Combined Carotid And Coronary Procedures: Nationwide Statistics Show That CAS Has Lower Adverse Events Rates Than CEA
  Presenters(s):Carlos H. Timaran, MD  
11:18 AM - 11:22 AM CAS Experience With Endovascular Flow Interruption Using The MOMA Device: Advantages And Limitations
  Presenters(s):Giancarlo Biamino, MD, PhD  
11:23 AM - 11:27 AM Use Of IVUS As An Important Quality Control Technique For CAS: Are There Risks To Its Use?
  Presenters(s):Dennis F. Bandyk, MD  
11:28 AM - 11:32 AM Debate 23: Screening To Detect Asymptomatic Carotid Stenosis Is Worthwhile So It Can Be Treated By CAS Or CEA
  Presenters(s):John (Jeb) W. Hallett, MD  
11:33 AM - 11:37 AM Debate 23: Screening To Detect Asymptomatic Carotid Stenosis Is A Bad Thing To Do Except As A Way To Get Patients On Statins: CAS Or CEA In Asymptomatic Patients Consumes Resources But Does Little To Prevent Stroke
  Presenters(s):Peter R.F. Bell, MD, FRCS, DSC, KBE  
11:38 AM - 11:42 AM Carotid Interventions For Stroke In Evolution: Indications, Techniques And Results: A 5-Year Experience
  Presenters(s):Sherif Sultan, MD, FRCS, EBQS-VASC  
11:43 AM - 11:47 AM CAS Setbacks: The Plan Was Flawed From The Beginning: Will CAS Recover?
  Presenters(s):Frank J. Criado, MD  
11:48 AM - 11:52 AM Carotid Stenting For Radiation Arteritis Has A High Complication And Restenosis Rate
  Presenters(s):Jean M. Panneton, MD  
11:53 AM - 11:59 AM Panel Discussion
Moderator(s): Herbert Dardik, MD / Kenneth Ouriel, MD, FACS, FACC  
11:59 AM - 12:03 PM Clinical Course Of Asymptomatic Carotid Stenosis With End-Diastolic Velocity 100-125 cm/sec: Stent Or Observe?
  Presenters(s):Thomas S. Riles, MD  
12:04 PM - 12:08 PM Technique Of Using An Interruption Of Flow Embolic Protection Device (MOMA) To Make CAS Safer
  Presenters(s):Gioacchino Coppi, MD  
12:09 PM - 12:13 PM How To Identify Stroke Threatening Plaques In Asymptomatic Patients By Contrast Duplex Or Biochemical Markers (Alpha NT pro BNP)
  Presenters(s):Afshin Assadian, MD  
12:14 PM - 12:18 PM The Value Of Pre-Procedure CTA To Improve The Outcomes Of CAS
  Presenters(s):Richard J. Powell, MD  
12:19 PM - 12:23 PM Restenosis After CAS Is Equal To That After CEA Based On Long-Term Results In 1,000 Patients
  Presenters(s):Piergiorgio Cao, MD, FRCS  
12:24 PM - 12:28 PM Transcervical CAS With Flow Reversal Eliminates Emboli During CAS: Why Does It Work And What Are The Adverse Event Rates With This Approach?
  Presenters(s):Enrique Criado, MD, FACS  
12:29 PM - 12:33 PM Outcomes After CEA: Is There A High Risk Population And Does This Have A Bearing On Some Of The CAS Trials Such As SAPPHIRE?
  Presenters(s):Richard P. Cambria, MD  
12:34 PM - 12:45 PM Panel Discussion
Refreshments Available
END OF SESSION XLII
previous next